Atlas Trials

Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)

Clinical trial NCT00703365 · COMPLETED

Trial details

NCT number
NCT00703365
Sponsor
Mahidol University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Hepatocellular
Start date
2008-02-01
Primary completion
2010-01-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.